GlassScriptPhysician profile
Ethan Caleb Geiger
NPI 1992210710
$12,383.16
in general payments reported to CMS, 2019-2025
34 companies · $1,187 in 2025
The $1,187 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,576 · 2022: $2,696 · 2023: $2,616 · 2024: $2,308 · 2025: $1,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,091 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,090.55 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,527.25 | 2021-2025 | Lifevest |
| Medtronic, INC. | $1,351.04 | 2021-2024 | Corevalve Evolut R, Hawkone |
| Novartis Pharmaceuticals Corporation | $936.71 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $827.79 | 2021-2025 | Farxiga, Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $797.35 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $765.08 | 2021-2025 | Verquvo, Belsomra |
| Abbott Laboratories | $740.50 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Aveir |
| Amgen INC. | $660.13 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $600.49 | 2021-2025 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $557.20 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $520.23 | 2021-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $373.83 | 2022-2025 | Onpattro, Amvuttra |
| Pfizer INC. | $371.27 | 2021-2025 | |
| Vifor Pharma, INC. | $329.10 | 2021 | |
| Esperion Therapeutics, INC. | $299.92 | 2021-2023 | Nexletol |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $280.92 | 2021-2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Zoll Respicardia, INC. | $215.65 | 2023 | Remede System |
| Amarin Pharma, INC. | $139.98 | 2021-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $130.73 | 2021-2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $120.72 | 2022-2025 | |
| Philips North America LLC | $120.28 | 2022-2023 | |
| Tactile Systems Technology INC | $115.75 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Kowa Pharmaceuticals America, INC. | $102.22 | 2021-2022 | |
| Atricure, INC. | $93.30 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Vital Connect, INC | $79.36 | 2023 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $58.29 | 2022-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $56.64 | 2024 | Arcalyst |
| Convatec INC. | $56.28 | 2023 | |
| Boston Scientific Corporation | $40.61 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $28.30 | 2023 | Exparel, Iovera |
| Angiodynamics, INC. | $26.84 | 2022 | |
| Arbor Pharmaceuticals, INC. | $25.91 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $20.24 | 2024 | Opsumit, Uptravi |
| Lexicon Pharmaceuticals, INC. | $13.25 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.